APA (7th ed.) Citation

A, G. (2026). Commentary on the Risks of Prescription GLP-1 Agonists in Patients on Psychiatric Medications. Journal of psychiatric practice, 32(3), 160. https://doi.org/10.1097/PRA.0000000000000931

Chicago Style (17th ed.) Citation

A, Garakani. "Commentary on the Risks of Prescription GLP-1 Agonists in Patients on Psychiatric Medications." Journal of Psychiatric Practice 32, no. 3 (2026): 160. https://doi.org/10.1097/PRA.0000000000000931.

MLA (9th ed.) Citation

A, Garakani. "Commentary on the Risks of Prescription GLP-1 Agonists in Patients on Psychiatric Medications." Journal of Psychiatric Practice, vol. 32, no. 3, 2026, p. 160, https://doi.org/10.1097/PRA.0000000000000931.